Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents
Zaki S. Seddigi(Umm al-Qura University), Ahmed Kamal(King Saud University), Saleh A. Ahmed(Umm al-Qura University), A. Prasanth Saraswati(University of Siena), M. Shaheer Malik(Umm al-Qura University), Hawazen A. Lamfon(Umm al-Qura University), Ahmad O. Babalghith(Umm al-Qura University)
Cited by 75
Related Papers
Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance
|Current Medicinal Chemistry|2017|127
Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions
|European Journal of Medicinal Chemistry|2017|119
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases
|Journal of Medicinal Chemistry|2019|115
The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
|Diagnostics|2022|61
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors
|Journal of Medicinal Chemistry|2021|55